New drug trial targets bulging eyes in thyroid disease
NCT ID NCT07462130
Summary
This early-stage study is testing an investigational drug called NTB003 for people with moderate-to-severe Thyroid Eye Disease (TED). The main goal is to see if the drug is safe and if it can reduce eye bulging and inflammation. The study will enroll about 74 adults who have had TED symptoms for less than a year or have chronic disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYROID EYE DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.